Augustin Jacob Landré-Beauvais

Augustin Jacob Landré-Beauvais (1772–1840) was a French surgeon best known for his description of rheumatoid arthritis.[1] Born in Orléans, he studied under Pierre-Joseph Desault and Marie François Xavier Bichat in Paris, and then from 1792 under Jean Louis Petit in Lyon. In 1796 he obtained an internship at the famed Salpêtrière Hospital, where he assisted Philippe Pinel. He was appointed professor of clinical medicine at the Salpêtrière in 1799. After the restoration, he also held the professorship at the Paris polytechnic school. He was removed in 1830 at the insistence of King Louis-Philippe of France.[2]

His description of rheumatoid arthritis, now regarded as the first modern-day account of the disease, incorrectly identified it as a form of gout.[1] Before Landré-Beauvais, several other physicians had already discovered that it may be distinct from gout.[3] The name "rheumatoid arthritis" itself was coined in 1859 by Alfred Baring Garrod.[4] Landré-Beauvais' other preserved work, Séméiotique, ou traité des signes des maladies (initially published in 1809) concerns the physical signs of medical illnesses in general.[5]

References

  1. 1 2 Landré-Beauvais AJ (1800). La goutte asthénique primitive (doctoral thesis). Paris. reproduced in Landré-Beauvais AJ (March 2001). "The first description of rheumatoid arthritis. Unabridged text of the doctoral dissertation presented in 1800". Joint Bone Spine 68 (2): 130–43. doi:10.1016/S1297-319X(00)00247-5. PMID 11324929.
  2. "Destins". Retrieved 2008-05-05.
  3. Aceves-Avila FJ, Medina F, Fraga A (April 2001). "The antiquity of rheumatoid arthritis: a reappraisal". J. Rheumatol. 28 (4): 751–7. PMID 11327245.
  4. Garrod AB (1859). The Nature and Treatment of Gout and Rheumatic Gout. London: Walton and Maberly.
  5. Landré-Beauvais AJ (1818). Séméiotique, ou traité des signes des maladies. Paris: J.A. Brosson.


This article is issued from Wikipedia - version of the Friday, April 08, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.